Literature DB >> 22539749

Allogeneic serum eye drops: time these became the norm?

Krishna G Badami, Malcolm McKellar.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22539749     DOI： 10.1136/bjophthalmol-2012-301668

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

Review 1.  Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products.

Authors:  Victor J Drew; Ching-Li Tseng; Jerard Seghatchian; Thierry Burnouf
Journal:  Front Med (Lausanne)       Date:  2018-02-23

Review 2.  Application of Novel Drugs for Corneal Cell Regeneration.

Authors:  Sang Beom Han; Yu-Chi Liu; Karim Mohamed-Noriega; Jodhbir S Mehta
Journal:  J Ophthalmol       Date:  2018-05-02       Impact factor: 1.909

Review 3.  Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.

Authors:  Federico Bernabei; Matilde Roda; Marina Buzzi; Marco Pellegrini; Giuseppe Giannaccare; Piera Versura
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

4.  Equine Umbilical Cord Serum Composition and Its Healing Effects in Equine Corneal Ulceration.

Authors:  Xavier Peyrecave-Capo; Nathalie Saulnier; Stéphane Maddens; Bérengère Gremillet; Isabelle Desjardins
Journal:  Front Vet Sci       Date:  2022-03-17

5.  Development and Optimization of Freeze-Dried Eye Drops Derived From Plasma Rich in Growth Factors Technology.

Authors:  Eduardo Anitua; María de la Fuente; Ignacio Alcalde; Cristina Sanchez; Jesús Merayo-Lloves; Francisco Muruzabal
Journal:  Transl Vis Sci Technol       Date:  2020-06-25       Impact factor: 3.283
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.